Selected growth businesses

Evonik is managed in accordance with the clear principles of state-of-the-art value man-agement. Active portfolio management, combined with efficient allocation of capital, is of high priority to our Group. We only invest in businesses that promise profitable growth and sustained value creation.

The following profiles outline some of these growth-drivers. More will be posted here in the future.

DL-methionine

Socio-economic megatrends are driving the development of our DL-methionine business: The world population, which already numbers seven billion people, is increasing by over 80 million a year. That will mean that demand for animal protein continues to rise steadily in the future.more

Isophorone Chemistry

Evonik is the market and technology leader in isophorone chemistry, with decades of experience in this field. We are the only company in the world that covers the entire value-added chain for isophorone and its derivatives.more